These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortex. Cohn D; Jackson RV; Gordon RD Pathology; 1983 Jul; 15(3):273-7. PubMed ID: 6316236 [TBL] [Abstract][Full Text] [Related]
31. [Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420]. GADRAT J; DELAUDE A; JORDA MF; MOREAU G Bull Mem Soc Med Hop Paris; 1962; 113():541-55. PubMed ID: 13896125 [No Abstract] [Full Text] [Related]
32. Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman. Shigematsu K; Nishida N; Sakai H; Igawa T; Suzuki S; Kawai K; Takahara O Endocr Pathol; 2009; 20(1):66-72. PubMed ID: 19199080 [TBL] [Abstract][Full Text] [Related]
33. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. Fischer E; Hanslik G; Pallauf A; Degenhart C; Linsenmaier U; Beuschlein F; Bidlingmaier M; Mussack T; Ladurner R; Hallfeldt K; Quinkler M; Reincke M J Clin Endocrinol Metab; 2012 Nov; 97(11):3965-73. PubMed ID: 22893716 [TBL] [Abstract][Full Text] [Related]
34. Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma. Giacchetti G; Ronconi V; Rilli S; Guerrieri M; Turchi F; Boscaro M Eur J Endocrinol; 2009 Apr; 160(4):639-46. PubMed ID: 19131503 [TBL] [Abstract][Full Text] [Related]
35. Conn's syndrome. Case report and a review of the syndrome of primary aldosteronism (SOPA). Grell GA; Hanchard B; Fletcher PR; Clarke WF; Williams W West Indian Med J; 1984 Mar; 33(1):48-54. PubMed ID: 6730466 [No Abstract] [Full Text] [Related]
36. Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells. Seccia TM; Caroccia B; Gomez-Sanchez EP; Vanderriele PE; Gomez-Sanchez CE; Rossi GP Hypertension; 2017 Nov; 70(5):867-874. PubMed ID: 28947616 [No Abstract] [Full Text] [Related]
37. Eplerenone use in primary aldosteronism during pregnancy. Cabassi A; Rocco R; Berretta R; Regolisti G; Bacchi-Modena A Hypertension; 2012 Feb; 59(2):e18-9. PubMed ID: 22146514 [No Abstract] [Full Text] [Related]
38. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375 [TBL] [Abstract][Full Text] [Related]
39. [Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism]. Vacher-Lavenu MC; Lellouch-Tubiana A; Louvel A; Daudet-Monsac M; Abelanet R Ann Pathol; 1982; 2(4):311-9. PubMed ID: 6297519 [TBL] [Abstract][Full Text] [Related]
40. Spironolactone inclusions in an aldosteronoma. Cain DR; Van de Velde RL; Shapiro SJ Am J Clin Pathol; 1974 Mar; 61(3):412-6. PubMed ID: 4360661 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]